RIFINAH 300 mg/150 mg, coated tablet 30 tablets
Active ingredients: Isoniazid, Rifampicin
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Coated tablet30 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- RIFINAH 300 mg/150 mg, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Nov 1991
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63898512CIP73295409CIP133400932954094Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RIFAMPICINEcomprimé | 300 mg · un comprimé | SA |
| ISONIAZIDEcomprimé | 150 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.